Home / Intelligence / News

Search

Trinity Named a Consulting Magazine “Fastest Growing Firm” for Third Year in a Row and “Best Small Firm to Work For”

Leading global life sciences consulting firm Trinity has been named to Consulting Magazine’s 2018 lists of “Best Small Firms to Work For” as well as the magazine’s list of “Fastest Growing Firms” for the third consecutive year. Consulting Magazine’s annual ranking of the industry’s “Best Firms to Work For” is based on employee survey responses regarding six areas of employee satisfaction including culture, career development, work/life balance, client engagement, compensation and benefits, and firm leadership. Consulting Magazine’s list of “Fastest…

Read Now

Trinity Shares Forecast Modeling Expertise in New Article for In Vivo

Experts from Trinity have published a bylined article in In Vivo. The article, titled, “You May Be Making These Drug Forecasting Mistakes,” breaks down the most common missteps in forecasting and highlights how to design and use the best models for the most accurate outcomes. In the article, Alex Chiang, Principal, and Adrian Watson, Senior Manager, Modeling and Analytics, discuss the top 10 most common drug forecasting errors, which fall into three broad categories: model design issues, model maintenance issues,…

Read Now

Trinity and Pfizer Present Panel Discussion on Tissue-Agnostic Cancer Drug Development

Waltham, MA—Global life sciences consulting firm Trinity today announced it will present the panel discussion, “Tissue-Agnostic Cancer Drug Development: An Emerging Paradigm Shift?” along with Pfizer and the Healthcare Businesswomen’s Association (HBA). The event, featuring perspectives from clinical, commercial, regulatory and market access experts, will take place at Pfizer’s headquarters in New York City on October 23, 2018 from 5:30-8 pm. Cancer treatment has made significant strides toward the promise of personalized medicine in recent years. With Keytruda’s tissue-agnostic MSI-H/dMMR…

Read Now

How Do You Put a Price Tag on Emerging Therapies?

Trinity issued a paper on asset valuation that explores the common methodologies for the valuation of pharma and biotech assets and highlights key considerations for capturing asset-specific nuances and accurately reflecting value.…

Read Now

Trinity to Acquire TGaS® Advisors

Click here to visit TGaS.com Next milestone in Trinity’s build, buy and partner growth strategy further accelerates the firm’s mission and vision to lead transformation in the life sciences industry Waltham, MA—Global life sciences consulting firm Trinity today announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. The acquisition marks another proof point in Trinity’s overarching growth strategy and builds upon previous successes and momentum including a strengthened…

Read Now

Trinity Welcomes Christian Frois, PhD to Leadership Team, Among 7 Leadership Team Promotions

Boston, August 20, 2018 – Leading global life sciences consulting firm Trinity today announced that it has welcomed new Principal, Christian Frois, PhD, to the firm as well as seven other individuals to its leadership team. Trinity also welcomes new full-time hires, totaling 40 new employees company-wide this year to date. Frois specializes in the development and evaluation of innovative commercial and evidence strategies for biopharmaceutical and medical device companies, and is a recognized expert on pricing, contracting and market…

Read Now

Trinity Team Attends Battle Summit to Hear How Cycle for Surviving Funding is Helping Rare Cancer Patients

Trinity’s Breanna Liponis and Alyssa Blaize recently attended Battle Summit to hear firsthand from Memorial Sloan Kettering doctors and researchers how Cycle for Survival funding is helping rare cancer patients everywhere. The team heard about important studies, initiatives and clinical trials funded through Cycle for Survival donors and participants for salivary gland cancer, pancreatic neuroendocrine tumors and advanced melanoma, among other areas. In addition, the team heard the latest updates on Loxo Oncology’s TRK fusion inhibitor, larotrectinib, developed with Cycle…

Read Now

Trinity Named a Forbes Best Management Consulting Firm for Third Consecutive Year

Leading global life sciences consulting firm Trinity today announced that it has been named to the Forbes America’s Best Management Consulting Firms 2018 list. Trinity has been named among the best management consulting firms every year since the inaugural ranking in 2016. The list, developed by Forbes in partnership with Statista, considers more than 1,300 consulting firms and surveys more than 1,000 senior executives to determine the best management consulting firms  based on recent performance and first-hand experience. The list…

Read Now

Trinity Releases New Report on Oncology Basket Trials

Leading global life sciences consulting firm Trinity today released a new whitepaper analyzing the oncology clinical trial pipeline to determine the extent to which basket trials are being utilized and, in particular, how many are likely to be registrational studies resulting in tissue-agnostic indications. Historically, basket trials have been used to explore multiple tumor types in one trial in order to prioritize the ones with the greatest response for further research. However, with Keytruda’s MSI-H and dMMR approval, basket trials…

Read Now

Trinity Employees Share Expertise at Leading Spring Events and Conferences

Boston, MA, May 15, 2018 – Trinity, a leading global life sciences consulting firm, today announced it will attend several important industry events across the U.S. this month. Covering topics ranging from innovation and endocrinology research to managed care, Trinity leaders are looking forward to presenting on and learning the latest updates in rare disease and patient advocacy, health care expenditure and the patient journey to continue to help clients make informed decisions in today’s continuously evolving business landscape. Life…

Read Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.